Society guideline links: Prevention of hepatitis B virus infection

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Diagnosis of hepatitis B".)

●(See "Society guideline links: Management of hepatitis B".)

●(See "Society guideline links: Hepatitis C virus infection".)

●(See "Society guideline links: Immunizations in adults".)

●(See "Society guideline links: Immunizations in children and adolescents".)

●(See "Society guideline links: Travel medicine".)

International

●World Health Organization (WHO): Guidelines for the prevention, diagnosis, care, and treatment for people with chronic hepatitis B infection (2024)

●WHO: Consolidated guidelines on HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and care for key populations (2022)

●WHO: Prevention of mother-to-child transmission of hepatitis B virus – Guidelines on antiviral prophylaxis in pregnancy (2020)

●WHO: Position paper on hepatitis B vaccines (2017)

●World Gastroenterology Organisation (WGO): Practice guideline on hepatitis B (2015)

Canada

●Public Health Agency of Canada (PHAC): Hepatitis B – For health professionals

●Canadian Paediatric Society (CPS): Position statement on infection prevention and control in paediatric office settings (2018, reaffirmed 2024)

●PHAC: Canadian Immunization Guide – Hepatitis B vaccine (2017)

●PHAC: Primary care management of hepatitis B – Quick reference (HBV-QR) (2014)

United States

●Advisory Committee on Immunization Practices (ACIP): Hepatitis B vaccine recommendations

•Adult immunization schedule – Recommendations for ages 19 years or older, United States (2025)

•Child and adolescent immunization schedule – Recommendations for ages 18 years or younger, United States (2025)

•Universal hepatitis B vaccination in adults aged 19-59 years – Updated recommendation, United States (2024)

•Universal hepatitis B vaccination in adults aged 19-59 years – Updated recommendations, United States (2022)

•Prevention of hepatitis B virus infection in the United States – Recommendations (2018)

●Centers for Disease Control and Prevention (CDC): Hepatitis B vaccination – Information for health care providers

•Hepatitis B perinatal vaccine information

•Hepatitis B vaccine administration

•Responding to HBV exposures in health care settings

•Screening and testing for hepatitis B virus infection – Recommendations, United States (2023)

•Sexually Transmitted Infections Treatment Guidelines – Hepatitis B virus (HBV) infection (2021)

●American Academy of Pediatrics (AAP): Red Book – Hepatitis B (2024)

●US Department of Health and Human Services (HHS): Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV – Hepatitis B virus infection (2023, reviewed 2024)

●Society for Healthcare Epidemiology of America (SHEA): White paper for the management of healthcare personnel living with hepatitis B, hepatitis C, or human immunodeficiency virus in US healthcare institutions (2020)

●US Department of HHS: Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV – Hepatitis B virus (2013)

Europe

●European Centre for Disease Prevention and Control (ECDC): Vaccine scheduler – Immunisation schedules by target disease: Hepatitis B

●European Association for the Study of the Liver (EASL): Clinical practice guidelines on the management of hepatitis B virus infection (2017)

United Kingdom

●UK Health Security Agency (UKHSA): The Green Book – Immunisation against infectious disease: Hepatitis B (2013, updated 2024)

●National Institute for Health and Care Excellence (NICE): Quality standard on hepatitis B (2014)

●NICE: Public health guideline on hepatitis B and C testing – People at risk of infection (2012, updated 2013)

India

●Asian Pacific Association for the Study of the Liver (APASL): Guidelines on hepatitis B virus in pregnancy (2022)

●APASL: Asian-Pacific clinical practice guidelines on the management of hepatitis B, 2015 update (published 2016)

Australia–New Zealand

●Australian Technical Advisory Group on Immunisation (ATAGI): The Australian Immunisation Handbook – Hepatitis B (2023)

●Asian Pacific Association for the Study of the Liver (APASL): Guidelines on hepatitis B virus in pregnancy (2022)

●Gastroenterological Society of Australia (GESA): Australian consensus recommendations for the management of hepatitis B infection (2022)

●APASL: Asian-Pacific clinical practice guidelines on the management of hepatitis B, 2015 update (published 2016)

Japan

●Asian Pacific Association for the Study of the Liver (APASL): Guidelines on hepatitis B virus in pregnancy (2022)

●APASL: Asian-Pacific clinical practice guidelines on the management of hepatitis B, 2015 update (published 2016)